Portugal – Pharmaceutical products – C/ BASE NO CPA 2026_6 - CABOZANTINIB 20 MG COMP + TEPOTINIB 225 MG COMP
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Acquisition of "CABOZANTINIB 20 MG COMP" and "TEPOTINIB 225 MG COMP" BASIS ON CPA 2026_6
Related Procurement Opportunities
Similar tenders in Pharmaceuticals